We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.
The Voice of MedTech in Asia
5-6 DECEMBER 2023
Innovation took centre stage as the key theme for MedTech Forum 2023. Engaging a diverse range of stakeholders from the Asia Pacific and across the globe, MedTech Forum 2023 fueled enriching discussions into the Future of MedTech innovation, including the game-changing impact of innovation on healthcare professionals, patient journeys, and the dynamic talent steering the MedTech landscape.
The Asia Pacific MedTech Forum 2023 proved that innovation is more than a buzzword with its theme of “Innovation Unleashing Human Potential”. Global and regional speakers ranging from representatives from the World Health Organisation, to health regulators from various countries, industry executives, tech evangelists, care providers, healthcare practitioners, payers and patient group representatives presented and engaged in discussions addressing critical issues facing the healthcare industry today.
Missed some sessions at MedTech Forum? Watch replays of the sessions at your own pace.
Session recordings are exclusively available to MedTech Forum physical and virtual delegates only. Please check your email for the password to access. Otherwise, please contact [email protected] for further assistance.
Click to view the MedTech Forum 2023 Programme.
APACMed Board Chairman, John Collings, will officially kick off the forum providing an overview of the Forum, elaborate on its theme, and introduce the concept of the three E’s. Through insightful reflections, he will share a roadmap for the forum, offering valuable perspectives on advancing innovation in the healthcare sector.
Bringing in the Patient Perspective
In her role as President of the Brain Tumour Society (Singapore), Melissa brings patient representation to this session, sharing a heartfelt and sincere narrative of the potential, challenges, and even pitfalls of medical innovation. It’s a compelling story that sheds light on the profound influence of MedTech innovation on patients’ lives.
Chairman, APACMed
President, Stryker, Asia Pacific
President
Brain Tumour Society (Singapore) Limited
As the global CEO of a MedTech giant, Thomas will elucidate the significance of innovation and the three E’s in the MedTech industry, also providing valuable insights into Roche’s unique innovation strategy, its evolution and implications for patients and talent.
Chief Executive Officer
Roche Group
Sharing candid insights into the significance of innovation in MedTech Industry, Lance reflects on Roche’s innovation strategy, including both its triumphs and tribulations. Both speakers jointly highlight the critical role that industry plays in shepherding medical innovation.
Head of Region
Roche Diagnostics Asia Pacific
CEO
APACMed
Step into the forefront of medical innovation with Dr Jordan in this enlightening session. Discover the vast potential of medical innovation as he provides a glimpse into the future with forward-looking predictions and how we can unlock innovation’s potential by upgrading human capital.
Author
A Human's Guide to the Future
This fireside chat delves into the implications of Innovation for the MedTech industry. A senior executive shares insights on their company’s balance between innovation and real-world adoption, aligning with the three E’s model. The subsequent dialogue between Jordan and the industry leader explores whether we’re pushing medical innovation too far in the Asia Pacific, and discusses practical approaches to aligning human skills with innovation, identifying key opportunities and risks.
Strategic Advisor
APACMed
Explore the Asian MedTech perspective with Terumo, a unique multinational rooted in the region. Sato San will take us on a journey through Terumo’s evolution, charting its progression from its origins in Asia to its current global stature, uncover essential elements that contributed to success in the Asian context, emphasizing the pivotal role of talent.
Global Group President & CEO
Terumo Corporation
Managing Director and Senior Partner
Boston Consulting Group
Session Moderator
Innovation is at the heart of MedTech, exploring new frontiers and revolutionizing the landscape of patient care.
Our Panel session on “Medical Innovation: Fulfilling Our Promise” will explore the complexities surrounding medical innovation in this thought-provoking panel discussion. Industry leaders will dive into the transformative power of innovation, the ecosystem’s readiness to embrace MedTech innovations and its impact on healthcare workforce, patients and healthcare industry as a whole.
Chief Medical Officer
GWS Medical
National Clinical Lead - AI and Digital Workforce, UK
NHS
General Manager & Senior Vice President, Asia Pacific Health Catalyst
Founder
Syndromes Without A Name (SWAN) Australia
Sr. Vice President Clinical Operations, Asia Pacific
bioMérieux
Vice President, Asia Region-led Markets
Medtronic
Asia Pacific Japan President
Siemens Healthineers
Director, Healthcare and Life Sciences, Asia Pacific
KPMG
Session Moderator
Embark on the journey of embracing innovation and human potential in this dynamic panel session.
Join the MedTech industry leaders addressing the challenges of embracing innovation, its impact on human potential, delving into what innovation signifies for each participating organization and industry’s pivotal role in advancing innovation.
President, Greater Asia
Becton Dickinson
Senior Vice President & President, Asia Pacific
Boston Scientific
Vice President, Asia
Baxter International
VP / General Manager, Asia
embecta
Senior Partner, Head of APAC Healthcare & Life Sciences
Bain & Company
Session Moderator
Commencing with an overview of MedTech Innovator Awards, this session will feature compelling pitches from top-selected start-ups and announce grand prize winners. The session will also witness an enlightening dialogue with industry leaders, sharing their experiences in corporate and start-up matchmaking, providing valuable insights into the collaborative dynamics shaping the MedTech landscape.
CEO Asia-Pacific
Olympus
VP, Strategic Alliances
MedTech Innovator
Director, Government Affairs and Market Access
APACMed
Divisional Vice President Government Affairs, Asia Pacific & Japan
Abbott Laboratories
Manager, Government Affairs and Market Access
APACMed
Senior Partner, APAC Healthcare and Life Sciences
Bain & Co
Sustainability & Environment Director
MedTech Europe
Policy Manager
Medical Technology Association of Australia (MTAA)
Expert Senior Manager, Sustainability
Bain & Co
Session Moderator
Market Access, and Public & Government Affairs Senior Manager
bioMérieux
Managing Director
Vista Health Pte Ltd
Manager, Government Affairs and Market Access
APACMed
Senior Director Health Economics & Reimbursement, OUS
Abbott
Deputy Director of Research,
St Vincent’s Hospital Melbourne;
Associate Professor,
Melbourne Medical School
Head of Market Access & HEOR, APAC
IPSOS
Session Moderator
Country Lead, India
APACMed
Chair of Public Affairs Committee, Orthopaedics Committee, and Strategy Management Office, AMDD
Chair of Healthcare Committee, and Vice-Chair of Govt Affairs Committee, ACCJ (American Chamber of Commerce Japan)
Managing Director, APAC
Avalere Health
Session Moderator
Senior Director, Market Access and Medical Affairs, APAC
Glaukos
China Lead
APACMed
VP, Health Practice
EDB
Head of Enterprise Risk Services KPMG Asia Pacific
China Life Science Advisory Partner
KPMG China
Director of Policy and Strategic Planning
Malaysia Medical Device Authority
Head of Team for Supervision and Certification of Medical Devices Distribution Facilities
Indonesia MoH
Group CEO
ARQon
Chief Medical Officer
GWS Medika
Chairman and CEO
Ustar
Director, Venture Creation and Growth, Innovation & Enterprise Group
A*STAR
Director
The Voices Project Asia
Health System Innovator
Independent
Chair and Research Professor, Global Health Department, School of Public Health;
Associate Dean, Institute for Global Health and Development
Peking University
Session Moderator
China Lead
APACMed
Professor, Dean, School of Medicine and Health Management Huazhong University of Science and Technology; Executive Director, Research Institute of NHSA
Huazhong University of Science and Technology
Professor, Dean, School of Medicine and Health Management Huazhong University of Science and Technology; Executive Director, Research Institute of NHSA
Huazhong University of Science and Technology
Assistant Director
MOH Office for Healthcare Transformation, Singapore
Partner
L.E.K. China
Session Moderator
Researcher, HUST Sub-Base
National Institute of Healthcare Security
Principal and Head of Real-World Evidence, Asia Pacific
IQVIA
Session Moderator
Reviewer
Division of Clinical and Biostatistics I, Center for Medical Device Evaluation (CMDE), NMPA
Global Press Officer; Deputy Director for Investment Promotion Department
Hainan International Economic Development Bureau
APAC Director, Regulatory Affairs, Quality And Compliance
Abbott
Session Moderator
Regulatory Affairs Manager
APACMed
Senior Regulatory Counsel, International Affairs
US Food and Drug Administration, IMDRF
Deputy Director-General of Health (Health Regulation), Assistant Commissioner (Cybersecurity – Healthcare)
Ministry of Health, Singapore
Principal, APAC
Clarivate Consulting
Head of Digital Health and Innovation Policy
Roche Diagnostics
Senior Regulatory Specialist,
Digital Health Branch,
Medical Devices Cluster,
Health Products Regulation Group
Health Sciences Authority, Singapore
Principal Reviewer
Pharmaceuticals and Medical Device Agency, Japan
First Assistant Secretary
Therapeutics Goods Administration, Australia
Assistant Director
Ministry of Food and Drug Safety, Korea
Reviewer
National Medical Products Administration, China
Principal, APAC
Clarivate Consulting
Session Moderator
Team Lead, Regulatory Convergence and Networks
World Health Organisation
Head Regulatory Policy Asia Pacific
Global Regulatory Policy & Intelligence
Roche Diagnostics
Deputy Director of Therapeutics Devices
Health Sciences Authority, Singapore
CEO
Medical Device Authority, Malaysia
IMDA Officer
Infrastructure and Medical Device Adminisration (IMDA) - Ministry of Health of Vietnam
IMDA Officer
Infrastructure and Medical Device Adminisration (IMDA) - Ministry of Health of Vietnam
First Assistant Secretary
Therapeutics Goods Administration, Australia
Principal Reviewer
Pharmaceuticals and Medical Device Agency, Japan
Head of Regulatory Affairs, Asia Pacific, Vision
Johnson & Johnson MedTech
Session Moderator
Head of Regulatory Affairs, Asia Pacific, Vision
Johnson & Johnson MedTech
APAC Regulatory Affairs Director
Varian Medical Systems (a Siemens Healthineers Company)
Head Regulatory Policy Asia Pacific
Global Regulatory Policy & Intelligence
Roche Diagnostics
APAC Director, Regulatory Affairs, Quality And Compliance
Abbott
Regulatory Affairs Manager
APACMed
Session Moderator
Manager, Diagnostics Projects
APACMed
Strategic Advisor
APACMed
Director Market Access, Asia Middle East and Africa
Illumina
Deputy Chair, The Lancet Commission on Diagnostics
Professor and Vice Chair, Dept of Pathology, University of Colorado
Director, Dept of Pathology & Lab Services Denver Health
CEO
FIND
VP, Outreach and Talent
Diagnostics Development Hub
Founder
Research For Impact
Chair and Research Professor, Global Health Department, School of Public Health; Associate Dean, Institute for Global Health and Development
Peking University
Associate Director, Diagnostics
Clinton Health Access Initiative
Senior Director
Vista Health
Session Moderator
Director
Rare Cancers Australia
Associate Professor (Clinical), Department of Clinical Oncology
The Chinese University of Hong Kong
Associate Director, Regulatory Affairs
Asia, Middle East and Africa (AMEA)
Guardant Health AMEA
Director
Rare Cancers Australia
Senior Consultant and Chairman, Division of Pathology
Singapore General Hospital;
Academic Chair, Pathology Academic Clinical Programme
SingHealth Duke-NUS
Senior Director
Vista Health
Session Moderator
Manager, Diagnostics Projects
APACMed
Director, Digital Health
APACMed
Head of Health Innovation
WisDM, the Institute for Digital Medicine at the NUS School of Medicine
Founder and former CEO
Syndromes Without a Name (SWAN) Australia
Chief Operating OfficerIHH Healthcare Singapore;
Chief Executive Officer
Mount Elizabeth Hospital
General Manager & Senior Vice President
Health Catalyst
Regional Director - Asia Pacific, Health Economics & Reimbursement
Abbott
Head, WHO Collaborating Centre for Digital Health
World Health Organization
Chief Digital Transformation Office & Expert Advisor of Health Technology to the Minister of Health
Ministry of Health, Indonesia
Director General, Benefit Listing Department
Health Insurance Review and Assessment Service (HIRA), Korea
Medical Director, Head, Medical Portfolio Management
Prudential Assurance Company Singapore
Strategic Advisor
APACMed
Session Moderator
Global Vice President AI
Styker
Head (Financing Redesign & mindline.sg)
Senior Consultant
MOHT
Founder
Health Parliament and Digital Health Academy (India)
Head of the WHO Innovation Hub
World Health Organisation
Head Global Digital and Regulatory Policy
Johnson & Johnson
Head of Life Sciences
KPMG Asia Pacific
Session Moderator
Assistant Manager, Digital Health
APACMed
Partner-in-Charge, Sydney and Japan
Jones Day
Partner-in-Charge, Singapore
Jones Day
Provost's Chair Professor,
Director, The Institute for Digital Medicine
National University of Singapore
Counsel
K&L Gates Straits Law LLC
Deputy Director-General of Health (Health Regulation) Assistant Commissioner (Cybersecurity – Healthcare)
Ministry of Health, Singapore
Vice President, IT Asia Pacific
Stryker
Regional Senior Editor
Tatler Gen. T
Session Moderator
Opening Remarks
Begin Innovation Day by with an overview of the day’s agenda and expectations, insights from the APACMed Start-up Committee, and the significance of community engagement in fostering innovation.
MedTech Innovation Build vs Buy Landscape
Expect a deep dive into industry trends, enlightening case studies, and valuable insights in a comprehensive presentation on the MedTech innovation build-vs-buy landscape in the Asia Pacific. In addition, a snapshot of insights observed from the APACMed matchmaking database will be released.
President, Asia & Latin America
ResMed
Head of SEA Healthcare & Life Sciences
LEK
Strategic Advisor
APACMed
(Session Moderator)
Embark on an insightful journey with a Start-up founder sharing
the remarkable story of Gauss Surgical, a patient monitoring start-up and its evolution into a fully-integrated business unit of Stryker.
Following the presentation will be a fireside chat exploring the intricacies of the journey and provide valuable insights for start-ups looking to make that corporate pitch.
Global Vice President AI
Stryker
Founder & CEO
NousQ
Engage in a dynamic panel discussion that delves into the “Realities of Matchmaking in the Asia Pacific”. Our expert panelists will share insights, experiences, and best practices, providing a comprehensive exploration of the challenges and successes within the region’s matchmaking landscape. Discover key strategies for community activation and gain practical insights to enhance your approach in the diverse and dynamic Asia Pacific market.
VP, Strategy & BD, APAC
Stryker
President, APAC
TMG Search
Principal
Baker McKenzie Wong & Leow
Head of SEA Healthcare & Life Sciences
LEK
Session Moderator
Head of New Business Development, China
Johnson & Johnson
Experience the convergence of ideas and solutions at the Inaugural APACMed Corporate Challenge Statement. Witness curated start-up matchmaking with 5-minute compelling pitches from each start-up, followed by Q&A session, dedicated time for fostering meaningful connections and collaboration within the MedTech ecosystem.
Head of R&D, Vision Care APAC
Johnson & Johnson
General Manager and Head of Finance
ResMed
National Clinical Lead - AI and Digital Workforce, UK
NHS
General Manager - Asia Pacific
Oliver Healthcare Packaging
Investment Director
Coronet Ventures
Marketing Director - Asia / General Manager - ANZ
embecta
Strategic Advisor
APACMed
VP, Strategic Alliances
MedTech Innovator
Click to view the MedTech Forum 2023 Speakers.
President, Stryker, Asia Pacific Chairman, APACMed
Author A Human’s Guide to the Future
Global Group President & CEO Terumo Corporation
Chief Executive Officer Roche Group
National Clinical Lead - AI and Digital Workforce, UK NHS
Manager, Government Affairs and Market Access APACMed
Team Lead, Regulatory Convergence and Networks World Health Organisation
VP, Strategic Alliances MedTech Innovator
China Lead APACMed
VP / General Manager, Asia embecta
Senior Director, Market Access and Medical Affairs, APAC Glaukos
Deputy Director-General of Health (Health Regulation), Assistant Commissioner (Cybersecurity – Healthcare) Ministry of Health, Singapore
Vice President, IT Asia Pacific Stryker
Vice President, Asia Region-led Markets Medtronic
VP, Health Practice EDB
Regional Director - Asia Pacific, Health Economics & Reimbursement Abbott
Expert Senior Manager, Sustainability Bain & Company
Associate Director, Regulatory Affairs Guardant Health AMEA
CEO APACMed
Head of Market Access & HEOR, APAC IPSOS
APAC Director, Regulatory Affairs, Quality And Compliance Abbott
Strategic Advisor APACMed
Chief Medical Officer GWS Medika
Head Regulatory Policy Asia Pacific Global Regulatory Policy & Intelligence Roche Diagnostics
Senior Partner, Head of APAC Healthcare & Life Sciences Bain & Company
Managing Director and Senior Partner Boston Consulting Group
Head of Government and Corporate Affairs AMEA Guardant Health
Professor, Dean, School of Medicine and Health Management Huazhong University of Science and Technology; Executive Director, Research Institute of NHSA Huazhong University of Science and Technology
Head of New Business Development, China Johnson & Johnson
Healthcare Research Managing Director FrontierView
President, Asia & Latin America ResMed
Head of Lifesciences, KPMG Asia Pacific KPMG Asia Pacific
Founder & CEO NousQ
President Brain Tumour Society (Singapore) Limited
Sustainability & Environment Director MedTech Europe
Head of Region Roche Diagnostics Asia Pacific
Associate Professor (Clinical), Department of Clinical Oncology The Chinese University of Hong Kong
Head of Enterprise Risk Services and China Life Science Advisory Partner KPMG
Director, Healthcare and Life Sciences, Asia Pacific KPMG
President, Greater Asia Becton Dickinson
Senior Vice President & President, Asia Pacific Boston Scientific
Principal, APAC Clarivate Consulting
Asia-Pacific General Manager Oliver Healthcare Packaging
General Manager & Senior Vice President, Asia Pacific Health Catalyst
Group CEO ARQon
Marketing Director - Asia / General Manager - ANZ embecta
Deputy Director of Research, St Vincent’s Hospital Melbourne; Associate Professor, Melbourne Medical School
Counsel K&L Gates Straits Law LLC
Head of Digital Health and Innovation Policy Roche Diagnostics
Researcher, HUST Sub-Base National Institute of Healthcare Security
Regulatory Affairs Manager APACMed
Deputy Director of Therapeutics Devices Health Science Authority, Singapore
Country Lead, India APACMed
CEO Asia-Pacific Olympus
Sr. Vice President Clinical Operations, Asia Pacific bioMérieux
Founder Syndromes Without A Name (SWAN) Australia
Head of Health Innovation WisDM, the Institute for Digital Medicine at the NUS School of Medicine
Global Vice President AI Stryker Corporation
Director, Digital Health APACMed
Divisional Vice President Abbott
Manager, Government Affairs and Market Access APACMed
Director, Venture Creation and Growth, Innovation & Enterprise Group A*STAR
Head of SEA Healthcare & Life Sciences LEK
Investment Director Coronet Ventures
Head Of Regulatory Affairs, Asia Pacific Johnson & Johnson Vision
Director, Government Affairs and Market Access APACMed
Market Access, and Public & Government Affairs Senior Manager bioMérieux
Asia Pacific Japan President Siemens Healthineers
Director Rare Cancers Australia
Director of Policy and Strategic Planning Malaysia Medical Device Authority
Vice President, Asia Baxter International
Founder Research For Impact
VP, Outreach and Talent Diagnostics Development Hub
CEO Medical Device Authority, Malaysia
Policy Manager Medical Technology Association of Australia (MTAA)
Provost's Chair Professor, Director, The Institute for Digital Medicine National University of Singapore
Chair and Research Professor, Global Health Department, School of Public Health; Associate Dean, Institute for Global Health and Development Peking University
Principal Reviewer Pharmaceuticals and Medical Device Agency, Japan
Head of R&D, Vision Care APAC Johnson & Johnson
VP, Strategy & BD, APAC Stryker
President, APAC TMG Search
General Manager and Head of Finance ResMed
Principal Baker McKenzie Wong & Leow
Chief Operating OfficerIHH Healthcare Singapore; Chief Executive Officer Mount Elizabeth Hospital
Head (Financing Redesign & mindline.sg) Senior Consultant MOHT
Regional Senior Editor Tatler Gen. T
Senior Regulatory Specialist, Digital Health Branch, Medical Devices Cluster, Health Products Regulation Group Health Science Authority, Singapore
First Assistant Secretary Therapeutics Goods Administration, Australia
Founder Health Parliament and Digital Health Academy (India)
Partner L.E.K. China
Chairman and CEO Ustar
Head, WHO Collaborating Centre for Digital Health World Health Organization
Director for Medical Devices Post Market Control Indonesia MoH
Director The Voices Project Asia
Health System Innovator Independent
Assistant Manager, Digital Health APACMed
Partner-in-Charge, Sydney and Japan Jones Day
Partner-in-Charge, Singapore Jones Day
Chief Digital Transformation Office & Expert Advisor of Health Technology to the Minister of Health Ministry of Health, Indonesia
Head of the WHO Innovation Hub World Health Organisation
Head Global Digital and Regulatory Policy Johnson & Johnson
APAC Regulatory Affairs Director Varian Medical Systems (a Siemens Healthineers Company)
IMDA Officer Infrastructure and Medical Device Adminisration (IMDA) - Ministry of Health of Vietnam
IMDA Officer Infrastructure and Medical Device Adminisration (IMDA) - Ministry of Health of Vietnam
CEO FIND
Senior Director Vista Health
Strategic Advisor APACMed
Chair of Public Affairs Committee, Orthopaedics Committee, and Strategy Management Office, AMDD Chair of Healthcare Committee, and Vice-Chair of Govt Affairs Committee, ACCJ (American Chamber of Commerce Japan)
Assistant Director MOH Office for Healthcare Transformation, Singapore
Head of APAC HEOR/RWE
IQVIA
Head of Team for
Supervision and Certification of
Medical Devices Distribution Facilities
Indonesia MoH
Director General, Benefit Listing Department
Health Insurance Review and Assessment Service (HIRA), Korea
Associate Director, Diagnostics Clinton Health Access Initiative
Senior Consultant and Chairman Division of PathologySingapore General Hospital; Academic Chair, Pathology Academic Clinical Programme, SingHealth Duke-NUS
Managing Director Vista Health Pte Ltd
Deputy Chair, The Lancet Commission on Diagnostics Professor and Vice Chair, Dept of Pathology, University of Colorado Director, Dept of Pathology & Lab Services, Denver Health
Director Market Access, Asia Middle East and Africa Illumina
Medical Director, Head, Medical Portfolio Management Prudential Assurance Company Singapore
Reviewer Center for Medical Device Evaluation, NMPA
Senior Regulatory Counsel, International Affairs US Food and Drug Administration, IMDRF
Assistant Director Ministry of Food and Drug Safety, Korea
Reviewer Division of Clinical and Biostatistics I, Center for Medical Device Evaluation (CMDE), NMPA
Senior Director Health Economics & Reimbursement, OUS Abbott
Managing Director, APAC Avalere Health
Global Press Officer; Deputy Director for Investment Promotion Department Hainan International Economic Development Bureau
APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.
© Asia Pacific Medical Technology Association Ltd. All rights reserved. Read Our Terms Of Use
John Collings is a senior-level leader with more than 20 years of experience in the medical technology and pharmaceutical industry. He started his career with Stryker in 2016, and he was appointed to President of Stryker Asia Pacific in 2020 after assuming leadership roles with increasingly expanded responsibilities.
John is focused on driving and developing high-performing teams across the region. Having lived and worked in seven different countries, John embraces diversity and inclusion. This lays the foundation in developing mission-driven, diverse and inclusive teams that has been key to Stryker’s success. Together with Stryker’s customers, the dynamic team delivers customer-centric and differentiated innovation that drives optimal patient outcomes.
Dr Jordan Nguyen is a leading Australian engineer, inventor and innovator, who is committed to improving as many lives as possible, as well as becoming a driving force behind both human and technological evolution as we move into the future.
An internationally renowned engineer for humanity, Jordan designs life-changing technologies to transform the lives of people with disabilities and the elderly through his role as founder of Psykinetic, a social business committed to bringing positive, sustainable and life-altering change. He also shares his adventures through documentaries across the world. Inspired by human endeavour, Jordan has big ambitions to see our world step consciously and creatively into a better future.
Mr. Shinjiro Sato has been the President and CEO of the company since 2017. Previously, he served as the Director and Managing Executive Officer from 2015 to 2017; Director and Senior Executive Officer from 2012 to 2015; Senior Executive Officer from 2012 to 2014; Group President of Cardiac and Vascular Business Group from 2011 to 2012; and Executive Officer, General Manager of Strategic Planning Dept. from 2010 to 2011. Mr. Sato served at Arthur Andersen Business Consulting (currently PwC Japan Group) from 1999 to 2004. He started his career at Joined Toa Nenryo Kogyo KK (currently JXTG Nippon Oil & Energy Corporation) in 1984.
Dr. Thomas Schinecker has been Chief Executive Officer of the Roche Group since 2023. He began his career at Roche in 2003 as part of a management development program. This was followed by various roles across six countries and three continents. Throughout his time at Roche, he served as Head of Marketing and Sales in Austria, Lifecycle Leader for Diagnostics’ Sequencing Solutions and General Manager of Roche Diagnostics in Sweden as well as in Germany. For two years, he led Roche Diagnostics’ largest business unit including Research and Development, before taking over the Diagnostics Division, which he led from October 2019 to December 2022. Dr Thomas Schinecker was born in Germany with German and Austrian citizenship and grew up in Singapore. He studied genetics in Salzburg, Austria, and received his PhD in molecular biology from New York University in 2003.
Benish joined APACMed in 2021 to support the Digital Health committee. Since October 2021, she has been working in the Government Affairs & Market Access committee to help build long term relationships with government stakeholders and promote smoother, more well-defined market access pathways.
Benish has close to a decade of prior experience in developing evidence based tailored therapeutic protocols for patient centric care in a multidisciplinary team at a tertiary hospital in India. Apart from that, while teaching as an Assistant Professor at a university, she also explored various innovative research projects which led her to pursue a Doctor of Philosophy. In Singapore, Benish completed an MBA in strategy & digital leadership from ESSEC Business School.
Benish is involved in various volunteering activities in Singapore and enjoys exploring new places and spending time with her family and friends.
Currently, Alicia manages cross-functional work of APACMed in China, including government affairs and market access, regulatory issues, digital health pathways, and China’s MedTech collaboration with the broader region.
Prior to joining APACMed, Alicia worked as the Chief Liaison Officer and senior international manager at CCCMHPIE for over 10 years, to drive bilateral and multilateral cooperation programs with a number of health-related government and non-government bodies in China.
She has extensive experience in driving projects under the governmental framework, public relations, policy analysis, advocacy programs, seminars, and events. She has been a key facilitator of multiple government-led bilateral and multilateral cooperation mechanisms, including the China-UK healthcare working group, China-CEEC Alliance for Public Health, China-ASEAN Healthcare Products Expo, etc. She was leading a number of global health projects, including WHO pre-qualification Studies on China’s MedTech industry.
An EU-certified conference interpreter, Alicia received her master’s degree in applied linguistics from the University of International Business and Economics. She has also completed her second master’s degree in Public Health from the Vanke School of Public Health at Tsinghua University.
James is Vice President / General Manager Asia at embecta, formerly part of BD and now one of the largest pure-play diabetes management companies in the world. Prior to embecta, James served as Vice President of the Diabetes Care business unit in Asia at BD. Before joining BD, James was the Global Marketing Director and Sales Director EMEA at MP Biomedicals, a leading provider of diagnostic products with global headquarters in California. James has also served as Sales & Marketing Director at Aeras Medical Pte Ltd, a medical solutions provider with a focus on diabetes diagnostics and management. Prior to Aeras Medical Pte Ltd he worked in LMA, a global leader and innovator of the laryngeal masks.
His experience in the medical industry has seen him take on appointments spanning R&D engineering, product and business management, P&L management, global marketing management and sales management in the APAC and EMEA regions. In the course of his career, he travelled widely and worked with professionals around the globe. He currently lives in Singapore.
Alice Chu is Senior Director, Market Access and Medical Affairs, Asia Pacific, for Glaukos Corporation, a U.S. ophthalmic medical technology and pharmaceutical company focused on transforming the standards of care in treating chronic eye diseases with novel therapies in glaucoma, corneal disorders, and retinal diseases. Her roles include improving patient access to the company’s innovations based on clinical and economic evidence that demonstrate value for money to governments, payers, and hospital administrators; advancing clinical evidence; and educating surgeons in the Asia Pacific region. Prior to Glaukos, Alice was involved in health policy and market access efforts at Boston Scientific and Johnson & Johnson Medical, both at the Southeast Asian and regional levels. She has worked in various of healthcare-related enterprises in the United States, such as medical communications and professional education. Alice received her PhD in Molecular and Biochemical Nutrition and Master of Public Health from the University of California, Berkeley. She also holds a Master of Business Administration from Singapore Management University. She is currently the co-president of the UC Berkeley Public Health Alumni Association and vice-chair of the Government Affairs & Market Access Committee for APACMed.
Adj Assoc/Prof (Dr) Raymond Chua is a Registered Public Health Specialist and Fellow with the Academy of Medicine. As Deputy Director-General of Health, he oversees the regulation of healthcare services, premises, and health digitalization in Singapore, to safeguard public health, assure patient safety and ensure healthcare innovations. He is concurrently designated as Assistant Commissioner for Cybersecurity in Healthcare, to assist in tracking and enhancing cybersecurity policies relating to Critical Information Infrastructures and Medical Devices in Singapore. He also chairs the Public Service Division’s Regulatory Advisory Group to provide guidance and broad direction in using regulatory tools and capability development of regulators in the public service.
Feng Dong is the Vice President of Asia Region-Led Markets for the Global Regions. He has been in the medical and healthcare industry for more than 30 years, and since joining Medtronic in 2004, has held several strategic positions, most recently serving as the Vice President and Managing Director of Medtronic Korea and Vice President for the Peripheral Vascular Operating Unit (OU) in Japan.
He is strongly committed to the principles of diversity, equity, and inclusion and is a firm believer that fostering a culture of inclusivity and respect can create innovative teams and make a positive impact on the lives of our patients.
Born in China, Feng Dong holds a Bachelor of Medicine from the University of Chinese Medicine School and spent five years in orthopedics treating patients in China. In his free time, Feng Dong enjoying spending time with his family and staying active through badminton, running, hiking, mountaineering, and skiing.
John Eng is VP of the Healthcare Division at the Singapore Economic Development Board (EDB). In his current role, he leads a team to engage with global companies and develop strategies to position Singapore as a hub for medical technology. Prior to this, he completed a secondment with the Food & Nutrition innovation strategy and initiatives at the Agency for Science Technology and Research and led the Agri-Food division at EDB. He was previously based in EDB’s Chicago Office from 2015-18 as Regional Director, Americas, facilitating investments in industries such as biomedical sciences, food & nutrition and professional services. John completed a MS in Bioengineering at the University of California, Berkeley and San Francisco and a BSc with Honours in Biological Sciences at Singapore’s Nanyang Technological University.
Arif Fahim is part of Abbott’s Asia Pacific Regional Leadership team for the Medical Devices Division and holds overall functional responsibilities for the Health Economics & Reimbursement (HE&R) capability in the region. In addition, Arif also leads the HE&R global taskforce on Early Value Assessment at Abbott. He has extensive experience in implementing access strategies in the region. This includes negotiating reimbursement approvals for a range of technologies and creation of new categories for innovative products, working closely with Government and commercial healthcare payers. Prior to his current role at APACMed, he served as Vice Chair of the India WG and Chair of the Health Economics, Pricing and Reimbursement Sub-group at AdvaMed. Arif has attended INSEAD, trained in HTA and Health Economics, from the Centre of Health Economics, University of York, UK, and is a Masters’ Degree holder in Marketing from the University of Durham, UK.
Gwyneth has over 10 years of experience working in corporate sustainability advisory and sustainable development. As a Senior Expert Manager at Bain & Company, Gwyneth works with companies to create value from sustainability, chart pathways to net zero and invest in nature-based solutions. Before joining Bain, Gwyneth was at Agility, a logistics and supply chain company, where she managed all aspects of sustainability, from human rights to reporting. She also served as a Senior Sustainability Advisor at Forum for the Future and as a Trade and Logistics Consultant for the World Bank Group in Latin America and the Caribbean. She holds a B.A. in Development Studies from Brown University, an M.A. in International Affairs from Columbia University’s School of International and Public Affairs, and a Micromasters Credential in Supply Chain Management from MITx. Her personal interests include climbing, yoga, and reading.
Dr. Karthik G M holds over 15 years of combined expertise in Regulatory Affairs (Medical Devices) and Biomedical Research & Development. As Associate Director of Regulatory Affairs for Asia, Middle East, and Africa at Guardant Health, he steers regulatory strategies and product submissions across these markets. Notably, at Singapore’s Health Sciences Authority (HSA), he was involved in drafting Product Specific Regulatory guidelines (NGS) for Singapore. His Ph.D. in Biomedical sciences from Karolinska Institutet, Sweden is accompanied by 8 impactful research articles. By fusing regulatory prowess with scientific insight, Dr Karthik G M propels innovation while ensuring compliance, underscoring his leadership, and lasting impact in both biomedical and regulatory domains.
Harjit was appointed CEO of APACMed in February 2019. Founded in 2014, the Asia Pacific Medical Technology Association is the only regional association to provide a unified voice for the medical technology industry in Asia Pacific.
Formerly she was EVP and CEO of Philips ASEAN & Pacific until October 2015. In this role, she managed a turnover of US$2 Billion and a team of 10,000 people in ten countries across its Healthcare, Lighting and Consumer Lifestyle sectors. Harjit spent twenty-five years with Philips holding a variety of international roles in General Management in Holland, Singapore, Dubai and Hong Kong.
Mr Adrien Gras is highly experienced leader in global pharmaceutical and medical device market access and HEOR. Adrien currently leads a team of experts in the field across the APAC region. He has been involved in all aspects of product development, from R&D activities such as drug target identification and drug discovery, pipeline commercial strategy, economic modelling, government reimbursement negotiation, and lifecycle management. He has published peer-reviewed journals and manuals in the fields of biochemistry, health economics and policy. Adrien was awarded a BSc in Biotechnology from Imperial College before completing an MRes in Structural Biology at Birkbeck College.
Mr. Jason (Jian) Guo earned double-bachelor’s degrees from STU, China and acquired master degree of International Business Administration from UBC (University of British Columbia), Canada. He is now working for Abbott Global Regulatory Service Dept. as regional RA director for APAC to oversee strategic regulatory planning and ensure regulatory compliance of Abbott medical device business in this region. Prior to join Abbott, Mr. Jason Guo had worked for multiple reputable US and European medical device MNCs, where he accumulated rich experiences in areas of QMS/GMP, post-market surveillance, regulatory approvals, intelligence, compliance, and policy shaping. Mr. Jason Guo is also serving APACMed RA Committee as vice chairperson to actively advocate regulatory harmonization, convergency, reliance and capacity building activities.
Chris Hardesty has dedicated his career and passion toward the health/care field. Having had the good fortune of working across more than 50 countries, he believes there is something to teach and something to learn from the various health system designs. His particular area of emphasis is around fostering public-private partnerships such that we can bring safe, effective, and economically-viable medical innovations to those in need.
Sam Karita is a core member of Boston Consulting Group’s Marketing, Sales & Pricing, Health Care, and Consumer practices.
He is also a Fellow at Bcg Henderson Institute (BHI) and BHI Japan lead.
Since joining BCG in 1997, Sam has worked closely with clients in a wide variety of industries, including pharmaceuticals, med-tech, consumer goods, media, entertainment, technology, and telecommunications. He has developed particular expertise in corporate / business strategy, innovation, large scale transformation, operational excellence across the value chain from R&D, manufacturing & supply chain and sales & marketing. He also has deep experience in supporting clients undertake transformation in digital and advanced analytics, working closely with Digital BCG colleagues.
Before joining BCG, Sam worked for the Industrial Bank of Japan, currently Mizuho Financial Group, where he was in charge of corporate finance for several major accounts. He is also a semiprofessional musician who records music and performs live in Tokyo.
Jasmine is a Corporate/Public Affairs & Communications Executive with 20 years of global, regional (Asia Pacific) & local market experience in protecting reputation, building global brands, effecting positive change & lifting employee engagement across the Public & Private sectors. Player-Coach with deep expertise in transforming high-growth, scaling businesses to deliver outcomes. Served on Leadership Teams for mega-brands, tech unicorns, and Fortune 500 companies successfully leading all corporate /public affairs & communication matters. Managing strategic demands in highly customer-focused, issues-rich, complex, cross-border, & multicultural environments environments, won multiple awards for delivering communication excellence & leadership. Change-agent & certified CSR/Sustainability Practitioner passionate about impacting lives, served on various industry, community-based & diversity committees.
Prof. Lan Yao, Dean of School of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Professor, Doctoral Supervisor, Ministry of Education New Century Excellent Talents, Executive Director of HUST Base of National Institute of Healthcare Security, Director of Primary Health Care Branch of China International Exchange and Promotive Association for Medical and Health Care, Vice Director of Health Insurance Branch of China Health Economics Association, Executive Director of China Health Insurance Research Association, Executive Director of Community Health Association of China, Vice President of Wuhan Medical Insurance Research Association, Vice President of Wuhan Community Health Association, Consulting expert of the Standing Committee of the 15th People’s Congress of Wuhan, Member of the Advisory Committee of Shenzhen Community Health Association. She has served as an advisor to the Health Bureau of the Macao Special Administrative Region. In addition, she was the chief editor of the second edition and third editions of textbook entitled “Medical Security”, with a total of eight books edited. As a project leader, she has presided over more than 80 scientific research projects of the National Natural Science Foundation of China, the National Health Commission, the Ministry of Human Resources and Social Security, the National Development and Reform Commission, the Ministry of Civil Affairs, the Ministry of Science and Technology, the World Health Organization Representative Office in China, the United Nations Children’s Fund, etc. More than 130 academic papers were published in various authoritative journals at home and abroad. She has received 8 awards, including the “China Medical Award” and the Third Prize of Hubei Provincial Scientific and Technological Progress. Main research areas: health economy, health policy, medical security, and primary health care.
Astra is responsible for leading external partnership and M&A initiatives for Johnson & Johnson MedTech in China, supporting the company’s innovation and growth agenda. She is also a member of the JJMT China Management Board and will assume responsibility for the Business Development function in China.
Astra joins us with extensive leadership and transaction experience from GE, where she led business development and marketing activities in greater China in support of GE businesses’ strategic marketing and inorganic growth initiatives.
Prior to this Growth Leader role, she served as GE China’s Managing Director for Corporate Business Development beginning in 2007. In this role, she led M&A activities in various industries, such as energy, mining, aviation, security and industrial intelligent platforms.
In addition to her experience in GE, Astra served as Corporate Development Director for Cargill in Asia, a leading global agricultural company.
Prior to that, Astra spent over 17 years in Motorola in market research, M&A and Venture Capital in Asia, where she was the founding member of Motorola Venture in China in 2004.
Astra received her MBA from J.L. Kellogg Graduate School of Management/University of Science and Technology in Hong Kong and a Bachelor of Economics from Macquarie University in Sydney, Australia.
Based in Singapore, Alec is the Managing Director for FrontierView’s Healthcare Research for Asia Pacific. His work focuses on providing support to healthcare business leaders in strategic business execution and the management of operational risks in Asia.
Today, Alec’s is responsible for coordinating on-going monitoring and analysis of healthcare systems across the Asia Pacific region, overseeing the firm’s editorial position, and managing a team of analysts in support of this view. Having previously built the firm’s healthcare practice for Latin America, Alec is a deep subject matter expert whose work spans Diagnostics, MedTech and Pharmaceutical business challenges. Alec also spends a considerable amount of his time engaging with stakeholders across the healthcare ecosystem, often constructing and leading initiatives to support businesses in developing solutions and coalitions to secure and expand market access for their innovative therapies.
Alec completed his bachelor’s degrees in political science at Oklahoma State University and attended the University of São Paulo, where he completed a master’s in international political economy. Alec previously held a position in the economic and political section of the US Department of State in Rio de Janeiro. Alec is fluent in Spanish, Portuguese, and proficient in French.
Frank is a Certified Practicing Accountant of CPA Australia. He has over 24 years of risk consulting experience in China and Asia Pacific. He became Partner in Charge of Risk Consulting for KPMG China in 2019. Risk Consulting includes Forensic, Internal Audit and Risk Compliance, Financial Risk Management, Actuarial and IT Advisory.
Frank has worked primarily in areas of internal audit, corporate governance, internal controls and risk management and strategic risk advisory. His industry focus includes manufacturing, life science, energy and resources and technology. Frank has been working closely with Chinese regulators and was involved in the drafting of various risk and control regulations.
Anastasia is passionate about partnering for outcomes, innovating for impact and delivering value for people across the healthcare ecosystem. Anastasia is a qualified AI/ML and Biomedical engineer who has over 20 years global and regional Life Sciences (MedTech, Pharma and Digital Health) and Private Healthcare experience within and with industry. Anastasia’s key technical focus areas include:
Mansoor is a management consultant with 15 years of experience in Life sciences and Technology sector. Mansoor specializes in areas of Commercial strategy including Opportunity assessment, Geo-expansion and launch planning, M&A support, Forecasting, Tender planning and assessment. His experience spans across JAPAC, Middle East and Established markets.
Previously, Mansoor was an Associate Principal at IMS Consulting group, where he led various Commercial strategy projects in Geo-expansion, Go-to-Market planning, Commercial Due diligence, Policy strategy and Tender optimization. Mansoor also led engagements at PRTM and ZS Associates, where he advised several MNCs on Operations and Commercialization aspects such as Supply chain optimization, Manufacturing ad demand planning, CMC development, Go-to-market strategy, Customer Segmentation, Resource allocation and Goal setting. Besides consulting, Mansoor also held strategic roles in industry, where he managed Corporate strategy and M&A initiatives.
Throughout his career, Mansoor has developed a strong interest in product commercialization planning. He has actively engaged in thought leadership and developed whitepapers on key aspects of commercialization. Mansoor holds an MBA from the Indian School of Business, Hyderabad, and a B. Tech from National Institute of Technology, Trichy in India.
Kenneth De Muynck is General Manager, Asia Pacific for Oliver Healthcare Packaging (Oliver) based in Singapore. In his role, Kenneth spearheads strategic growth opportunities for Oliver in the region, leveraging his extensive multi-market experience in healthcare and life sciences multinational companies (MNCs). This includes providing direction and oversight to capital projects, improving productivity and customer experiences through championing process excellence, driving talent management efforts, and maintaining deep relationships with key industry stakeholders. Prior to joining Oliver, he held senior roles at life sciences company Cytiva (previously GE HealthCare Life Sciences) and was responsible for driving service sales and commercial excellence across Southeast Asia, Australia, New Zealand, South Korea, Japan, and India. He also oversaw strategy and business development in areas such as manufacturing, inventory, and sales operations, and has nearly two decades of experience in the life sciences industry. Kenneth graduated from Nottingham Trent University with a bachelor’s degree (with Honours) in International Business. He also holds an Executive MBA from Vlerick Business School, a Masters in Global Management from the University of Antwerp Management School in Belgium, and a “Candidate in Law” from the Catholic University of Brussels.
Farhana Nakhooda, GM & SVP Health Catalyst, Asia Pacific, leads the overall vision and growth strategy of the Health Catalyst business across Asia Pacific. She is passionate about improving healthcare outcomes, access to care as well as decreasing healthcare costs across the APAC region. She has extensive experience with engagement at the intersection of medicine, technology, AI and analytics. Prior to joining Health Catalyst, Farhana was the IBM Healthcare & Life Sciences solutions leader for Asia Pacific for 18 years where she played a key role in digitally enabling healthcare transformation projects across Asia Pacific, Eastern Europe and Middle East/Africa. She has more than 25 years of international experience in the healthcare and life sciences industry as a medical researcher and as a subject matter expert. Farhana has a Bachelor of Science degree (with Honors), in which she majored in Biology and Biochemistry, at the University of British Columbia. She completed her MBA at Monash Mt Eliza Business School in Melbourne, Australia.
May had her start in the In-Vitro Diagnostics (IVDs) industry since 1990s. Within a decade of work with the Health Sciences Authority (HSA) in Singapore, she played a key role in establishing the medical devices branch and also, the local and regional medical device guidance. Subsequently, she became the Regulatory Director at Biosensors International Group, a manufacturer of interventional cardiology drug-device products for a number of years before setting up ARQon. May also the Regulatory and Quality Director in Endofotonics, a start-up manufacturer for In vivo Molecular Diagnostic (IMDx). Her experience in the design and manufacturing sites as well as in the commercial industry and as the local regulator enables her to guide all relevant departments during the entire product life cycle on the regulatory strategy and documentation to meet the global registration requirements and compliance.
Jacqueline brings with her more than 20 years of marketing experience in the healthcare and consumer technology sectors. She is a competent and independent marketer with a wealth of experience in strategy development, brand marketing, new product introductions, campaign development, digital marketing, market research, and marketing analytics. She has successfully led and implemented cross-functional projects across APAC & Japan region. Having held regional and global roles in organizations such as Novartis Consumer Health (CIBA VISION Division, Johnson & Johnson Vision (formerly Abbott Medical Optics), Nokia and Samsung, Jacqueline has a proven track record of managing cross-functional internal and external stakeholders, and possesses excellent cross-cultural communication and presentation skills. Overall, a self-motivated and results-oriented professional with strong interpersonal skills, and thrives on challenges to achieve goals.
A/Prof Tam Nguyen has over 20 years of working in clinical trials, health and medical research and research innovation sector. He is the deputy director of research at St Vincent’s Hospital Melbourne, part of the second largest healthcare provider in Australia.
Tam sits on the Investment Committee for H3Healthcare fund. He advises Health-Tech and MedTech start-ups from Australia and Singapore. He is a regular invited speaker at national and international conferences and holds academic appointment with Melbourne Medical School and Monash Medical School – two of the world top 30 (and APAC top 5) medical schools.
Lucas Nicolet-Serra is counsel at K&L Gates Straits Law LLC, the Singapore office of global law firm K&L Gates. Lucas focuses his practice on commercial, regulatory, and transactional work in the life sciences, telecommunications, and fintech sectors. He has extensive experience advising fintech and health-tech companies on legal, regulatory, and policy developments across Southeast Asia.
Johan leads Software Group within the Medicines and Healthcare products Regulatory Agency (MHRA). Software Group are responsible for most aspects of regulating software as a medical device (AI included) and work to ensure these devices are acceptably safe and deliver for patients. He was a co-author of Good Machine Learning Practice for Medical Device Development, has been involved in the development of various reporting standards for AI such as DECIDE-AI, and represents the UK in several international fora such as the AI Medical Device Working Group at the International Medical Device Regulators’ Forum. Previously, Johan was a Senior Policy Analyst (Law and Regulation) with the PHG Foundation, specialising in the regulation of digital health and genomic technology and led work on how medical device and data protection regulation applies to AI. Johan has four degrees, the last being a BA in Law from Wolfson College, University of Cambridge.
Dr. Pei Li is a Researcher of HUST Sub-Base of National Institute of Healthcare Security. Dr. Pei Li graduated from Peking Union Medical College and served as chief physician in the First Affiliated Hospital of Tsinghua University and the People’s Liberation Army General Hospital (301 Hospital). He also has extensive experience working in non-public hospitals and has been a core member of the Hospital Management Center of China Resources Medical since 2015.
In 2020, Cindy joined APACMed, offering her dedicated support to the Digital Health Committee. The journey continued in 2021, as she took the helm of the Legal, Ethics, and Compliance Committee. This role enabled her to play a key part in APACMed’s mission to enhance business standards across the APAC region. As 2023 unfolded, she took on the leadership of the APACMed Regulatory Affairs Committee. Through this role, she continues to shape the healthcare landscape in the APAC region, reflecting her unwavering dedication to excellence and innovation.
Before her time at APACMed, Cindy’s career unfolded in France, where she practised as a pharmacist. Her days revolved around ensuring patients received the medications they needed and providing essential guidance. This hands-on experience allowed her to collaborate seamlessly with fellow healthcare professionals, gaining valuable insights into pharmaceuticals, medical devices, and therapeutic approaches that enhance patients’ lives.
Cindy holds a Pharm D from the renowned French University François Rabelais, which laid the foundation for her deep understanding of pharmaceutical sciences. To augment her medical knowledge with business skills, she pursued an Advanced Master’s in Strategy and management of International Business (SMIB) from ESSEC Business School Asia Pacific.
Ms. Low is a regulatory professional with over 10 years of experience in the medical devices sector. She currently serves as the Deputy Director of the Therapeutic Devices Branch (TDB) of Medical Devices Cluster (MDC), HSA where she oversees the branch operations and is responsible for decision-making and developing regulatory policies.
During her time in HSA, Ms. Low also leads the teams working on special access route, dealer licensing and consultation team that supports companies in the development of innovative technologies.
Ms. Low also represents Singapore in the International Medical Device Regulators Forum (IMDRF) Medical Device Clinical Evaluation workgroup, where she collaborates with overseas regulators and industry representatives in the review of IMDRF guidance documents. Her regional portfolio includes participation in the Medical Device Product Working Group (MDPWG), and current ASEAN Medical Device Committee (AMDC) in continuing the work to support the ASEAN Medical Device Directive (AMDD) implementation.
Adip comes with 12+ years of multi-sector experience across Government Relations, Policy Advocacy, Stakeholder Engagement and Corporate Communications having worked in corporate, consulting as well as government settings. In his last role, Adip worked with APCO Worldwide – a global public affairs firm with a 7+ years tenure consulting fortune 500 companies, Not-for-profits, associations among others. Prior to joining APCO, Adip served in corporate affairs roles with respected multinationals like Alstom and Ingersoll Rand. He started his career with MSL Group and executed projects for Deloitte and the 2010 Commonwealth Games in New Delhi. Adip holds a Master of Business Administration with distinction from Heriot-Watt University, UK and a Diploma in Public Relations and Corporate Communications from Xavier Institute of Communications, Mumbai. Additionally, he holds a certification in public policy from the Takshashila Institution and received the Kautilya Fellowship from India Foundation and the Ministry of External Affairs, Govt of India (2019 and 2020).
Prior to joining Olympus, Marc held several management positions working for a variety of technology-focused companies, including Philips and LG Electronics. His career spans numerous countries and continents including South Africa, The United Kingdom, Europe, Australia, and most recently Singapore.
Marc commenced his career with Olympus in 2004 in Sydney Australia where he served as the Imaging Division Managing Director for Australia and New Zealand.
In 2019, Marc was promoted to Chief Executive Officer of Olympus Corporation of Asia Pacific, with full strategic and operational responsibility for the APAC Region.
To achieve the Olympus purpose of Making people’s lives healthier, safer and more fulfilling, Marc is focused on establishing Olympus APAC as a MedTech organization known for excellence throughout the region.
Marc was born in South Africa and holds commerce degrees from The Cape Peninsula University of Technology and The University of South Australia. He is married with two children and enjoys spending time with his family and the occasional ultra-marathon or competitive swim.